This invitation-only event with Dr. Lee Newcomer, medical oncologist and former UnitedHealth executive, and Clynt Taylor, CEO of Trapelo Health, brings together health plan executives to discuss the enormous complexities and opportunities in managing precision oncology.

The 12-15% growth rate in cost of precision medicine for oncology means that the time is now to address outdated decision-making and reimbursement practices that threaten patient accessibility and the speed of progress in this area of healthcare.

Specifically, during this roundtable we will discuss the top challenges in precision medicine today, including:
 

1. Providing equal access for every patient who can potentially benefit

2. The explosion of new biomarkers, tests and therapies

3. The enormous complexity that inhibits decision making

4. Why traditional prior authorization can’t scale 

5. The skyrocketing costs of testing and treatment and how no smaller cohort of your membership drives higher financial risk
    

For more information, please contact Deana Mason: dmason@trapelohealth.com